Orthopedic infections, including fracture-related infection and periprosthetic joint infection (PJI), remain difficult to eradicate because bacteria within biofilms exhibit high tolerance to systemic antibiotics. Conventional antibacterial strategies based on minimum inhibitory concentration often fail in the biofilm environment, where substantially higher antimicrobial concentrations are required. Continuous local antibiotic perfusion (CLAP) has emerged as a technique that enables sustained delivery of high local antibiotic concentrations directly to the infected site while providing continuous drainage using negative pressure wound therapy.
The narrative review by Hyonmin Choe et al summarizes the principles, technical aspects, clinical indications, and reported outcomes of CLAP. A literature search of the MEDLINE database was conducted using the term “continuous local antibiotic perfusion.” Clinical studies describing the use of CLAP in orthopedic infections, including case reports, case series, and retrospective studies, were reviewed. Perfusion strategies (iMAP, iSAP, iJAP, and TRAP), antibiotic regimens, safety considerations, and current limitations were analyzed.
The key findings were:
• CLAP enabled delivery of high local antibiotic concentrations exceeding the minimum biofilm eradication concentration while maintaining relatively low systemic exposure.
• Favorable outcomes for infection control, implant retention, and fracture union, were reported across various intractable infections, including fungal PJI.
• Complications such as transient elevations in serum antibiotic levels and renal dysfunction were reported but appeared to be infrequent.
• Although CLAP has shown potential utility in refractory infections, further high-quality studies with rigorous safety evaluations are required to strengthen the evidence base.
The authors concluded – “CLAP is an emerging therapeutic strategy for orthopaedic infections that enables the delivery of high local concentrations of antibiotics while simultaneously providing continuous drainage. Its clinical utility has been reported in a range of musculoskeletal infections; however, the supporting evidence is predominantly limited to case reports and retrospective analyses. Future priorities include the conduct of prospective randomized controlled trials, the development of standardized treatment protocols, and systematic evaluation of long-term safety.”
Further reading:
Continuous Local Antibiotic Perfusion: A Novel Technique for the Treatment of Orthopaedic Infections
Hyonmin Choe et al
JBJS Open Access d 2026:e25.00212.
http://dx.doi.org/10.2106/JBJS.OA.25.00212
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.